GBIO
Price
$0.40
Change
+$0.02 (+5.26%)
Updated
Jun 3 closing price
Capitalization
25.78M
63 days until earnings call
XBIT
Price
$2.94
Change
+$0.05 (+1.73%)
Updated
Jun 4, 10:41 AM (EDT)
Capitalization
88.11M
72 days until earnings call
Interact to see
Advertisement

GBIO vs XBIT

Header iconGBIO vs XBIT Comparison
Open Charts GBIO vs XBITBanner chart's image
Generation Bio
Price$0.40
Change+$0.02 (+5.26%)
Volume$521.55K
Capitalization25.78M
XBiotech
Price$2.94
Change+$0.05 (+1.73%)
Volume$500
Capitalization88.11M
GBIO vs XBIT Comparison Chart
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. XBIT commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a StrongBuy and XBIT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (GBIO: $0.40 vs. XBIT: $2.89)
Brand notoriety: GBIO and XBIT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 102% vs. XBIT: 85%
Market capitalization -- GBIO: $25.78M vs. XBIT: $88.11M
GBIO [@Biotechnology] is valued at $25.78M. XBIT’s [@Biotechnology] market capitalization is $88.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileXBIT’s FA Score has 1 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • XBIT’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIT is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 5 TA indicator(s) are bullish while XBIT’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 5 bullish, 1 bearish.
  • XBIT’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than XBIT.

Price Growth

GBIO (@Biotechnology) experienced а +7.58% price change this week, while XBIT (@Biotechnology) price change was -2.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

XBIT is expected to report earnings on Aug 15, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XBIT($88.1M) has a higher market cap than GBIO($25.8M). XBIT YTD gains are higher at: -26.835 vs. GBIO (-62.377). XBIT has higher annual earnings (EBITDA): -43.6M vs. GBIO (-69.2M). XBIT has more cash in the bank: 183M vs. GBIO (158M). XBIT has less debt than GBIO: XBIT (10M) vs GBIO (87.6M). GBIO has higher revenues than XBIT: GBIO (24.6M) vs XBIT (0).
GBIOXBITGBIO / XBIT
Capitalization25.8M88.1M29%
EBITDA-69.2M-43.6M159%
Gain YTD-62.377-26.835232%
P/E RatioN/AN/A-
Revenue24.6M0-
Total Cash158M183M86%
Total Debt87.6M10M876%
FUNDAMENTALS RATINGS
XBIT: Fundamental Ratings
XBIT
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
44

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GBIOXBIT
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
68%
Declines
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 6 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLAR3.340.20
+6.21%
Clarus Corp
LI29.511.69
+6.07%
Li Auto
NCNO27.261.07
+4.09%
nCino
SCSC41.371.35
+3.37%
ScanSource
CHR1.380.02
+1.85%
Cheer Holding

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+3.72%
CCCC - GBIO
48%
Loosely correlated
+11.28%
FHTX - GBIO
46%
Loosely correlated
+4.56%
ATNM - GBIO
46%
Loosely correlated
+3.70%
IDYA - GBIO
46%
Loosely correlated
+1.98%
ABOS - GBIO
45%
Loosely correlated
+4.00%
More

XBIT and

Correlation & Price change

A.I.dvisor indicates that over the last year, XBIT has been loosely correlated with GBIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if XBIT jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIT
1D Price
Change %
XBIT100%
+1.05%
GBIO - XBIT
41%
Loosely correlated
+3.72%
GLSI - XBIT
40%
Loosely correlated
-0.93%
NAUT - XBIT
38%
Loosely correlated
+4.92%
ABOS - XBIT
38%
Loosely correlated
+4.00%
ORMP - XBIT
36%
Loosely correlated
-5.04%
More